|
2024
|
Invention
|
Cell culture process.
Polypeptides having target levels of C-terminal variants are described. |
|
|
Invention
|
Pharmaceutical compositions comprising nipocalimab. Pharmaceutical compositions of anti-FcRn anti... |
|
|
Invention
|
Compositions and methods related to engineered fc constructs.
The present invention relates to c... |
|
|
Invention
|
Compositions and methods for treating hemolytic disease of the fetus and newborn. Provided herein... |
|
2023
|
Invention
|
Engineered fc constructs.
The present disclosure relates to engineered IgG Fc constructs and use... |
|
|
Invention
|
Fcrn antibodies and methods of use thereof.
The present invention features antibodies that bind ... |
|
|
Invention
|
Fcrn antibodies and methods of use thereof.
The present invention features antibodies that have ... |
|
|
Invention
|
Sialylated glycoproteins.
Glycoproteins having particular sialylation patterns, and methods of m... |
|
|
Invention
|
Antibodies against integrin alpha 11 beta 1 and uses thereof. Embodiments that are provided for h... |
|
|
Invention
|
Antibodies against integrin alpha 11 beta 1 and uses thereof |
|
|
Invention
|
Methods related to biologics.
The present disclosure relates to the characterization and product... |
|
|
Invention
|
Sialylated glycoproteins.
Pharmaceutical preparations containing polypeptides having particular ... |
|
|
Invention
|
Compositions and methods related to engineered fc constructs.
The present disclosure relates to ... |
|
|
Invention
|
Methods for predicting response to treatment. Described herein are methods for treating rheumatoi... |
|
2022
|
Invention
|
Control of copolymer compositions.
Methods of making copolymers are described. |
|
|
Invention
|
Methods for the treatment of neurodegeneration.
The invention encompasses the discovery that Fc-... |
|
|
Invention
|
Fcrn antibodies and methods of use thereof.
The present application features antibodies that bin... |
|
|
Invention
|
Compositions and methods for treating pediatric myasthenia gravis.
Composition and methods for t... |
|
|
Invention
|
Compositions and methods for treating pediatric myasthenia gravis. Composition and methods for tr... |
|
2021
|
Invention
|
Antibodies against integrin alpha 11 beta 1.
The present disclosure includes antibodies that spe... |
|
|
Invention
|
Antibodies against integrin alpha 11 beta 1. The present disclosure includes antibodies that spec... |
|
|
Invention
|
Sialylated glycoproteins.
Methods for measuring disialylated Fc glycan in a biological sample ar... |
|
|
Invention
|
Sialylated glycoproteins. Methods for measuring disialylated Fc glycan in a biological sample are... |
|
|
Invention
|
Engineered fc constructs. The present disclosure relates to engineered IgG Fc constructs and uses... |
|
|
Invention
|
Fcrn antibodies and methods of use thereof.
Methods for dosing of antibodies to human neonatal F... |
|
|
Invention
|
Glycoproteins with anti-inflammatory properties.
Glycoproteins having particular sialylation pat... |
|
|
Invention
|
Sialylated glycoproteins.
Described herein are liquid pharmaceutical compositions comprising imm... |
|
|
Invention
|
Hypersialylated immunoglobulin.
Described herein are methods of preparing a hypersialylated huma... |
|
|
Invention
|
Compositions and methods related to engineered fc constructs. The present invention relates to co... |
|
|
Invention
|
Methods for measuring consumption of amino acid n-carboxyanhydrides during manufacture of glatira... |
|
|
Invention
|
Hyper-sialylated immunoglobulin.
Methods for preparing hypersialylated IgG are described. |
|
|
Invention
|
Preparation and purification of hypersialylated igg.
Methods for preparing and purifying hypersi... |
|
|
Invention
|
Preparation and purification of hypersialylated igg. Methods for preparing and purifying hypersia... |
|
|
Invention
|
Hyper-sialylated immunoglobulin. Methods for preparing hypersialylated IgG are described. |
|
|
Invention
|
Methods of making hyper-sialylated immunoglobulin.
Disclosed herein are methods galatosylating I... |
|
|
Invention
|
Enzymes for sialylation of glycans.
Described herein are fusion proteins, e.g., fusion proteins ... |
|
2020
|
Invention
|
Fcrn antibodies and methods of use thereof.
Methods for intravenous dosing of antibodies to huma... |
|
|
Invention
|
Sialylated glycoproteins.
Pharmaceutical preparations containing hypersialylated immunoglobulins... |
|
2019
|
Invention
|
Methods of producing ustekinumab.
Methods of manufacturing an ustekinumab product with a target ... |
|
|
P/S
|
Providing patient access to pharmaceuticals, namely, dispensing of pharmaceuticals; providing inf... |
|
|
P/S
|
Providing patient access to pharmaceuticals (terms
considered too vague by the International Bur... |
|
|
Invention
|
Compositions and methods related to engineered fc-antigen binding domain constructs.
The present... |
|
|
Invention
|
Compositions and methods related to engineered fc-antigen binding domain constructs targeted to c... |
|
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals and clinica... |
|
2018
|
Invention
|
Fcrn antibodies and methods of use thereof. The present invention features antibodies that bind t... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases |
|
2017
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases. |
|
|
P/S
|
Pharmaceutical research and development services; Development of pharmaceutical preparations and ... |
|
|
P/S
|
Pharmaceutical research and development services; drug discovery services; testing, inspection, o... |
|
|
Invention
|
Methods related to engineered fc constructs.
The present invention relates to methods of using b... |
|
2004
|
P/S
|
Reagents for scientific and medical research. Laboratory or electronic apparatus for sequencing p... |
|
|
P/S
|
Reagents for scientific and medical research. Diagnostic and therapeutic pharmaceutical preparati... |
|
|
P/S
|
Diagnostic and therapeutic pharmaceutical preparations or reagents for clinical or medical labora... |
|
|
P/S
|
reagents for scientific and medical research |
|
|
P/S
|
Diagnostic and therapeutic reagents for clinical or medical laboratory use; diagnostic reagents f... |
|
2002
|
P/S
|
DIAGNOSTIC AND THERAPEUTIC PHARMACEUTICAL PREPARATIONS OR REAGENTS FOR CLINICAL OR MEDICAL LABORA... |
